🇺🇸 Experimental 23-valent Pneumococcal in United States

Experimental 23-valent Pneumococcal (Experimental 23-valent Pneumococcal) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Experimental 23-valent Pneumococcal in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Experimental 23-valent Pneumococcal approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Experimental 23-valent Pneumococcal in United States?

Sinovac Biotech Co., Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.